D-0544-2024 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- June 12, 2024
- Initiation Date
- May 17, 2024
- Termination Date
- January 29, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 463 Cartons
Product Description
Tivicay PD (dolutegravir) 5mg Tablets for Oral Suspension, 60-count bottles, Each carton contains one bottle of 60 tablets, one 30-mL dosing cup and one 10-mL oral dosing syringe, Rx Only, Mfd for: ViiV Healthcare Durham, NC, 27701, By: GlaxoSmithKline Durham, NC 27701, NDC 49702-255-37
Reason for Recall
Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR.
Distribution Pattern
Nationwide within the United States
Code Information
Lot #: AG4M, Labeled Expiry date on carton May 2026, correct Exp. Date 04/2025